{"id":1000,"date":"2026-06-23T13:00:35","date_gmt":"2026-06-23T13:00:35","guid":{"rendered":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/"},"modified":"2026-06-23T13:00:35","modified_gmt":"2026-06-23T13:00:35","slug":"how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada","status":"publish","type":"post","link":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/","title":{"rendered":"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada"},"content":{"rendered":"<p data-blockid=\"replaceWithId\" data-depth=\"0\">Many companies still struggle to connect labeling, claims, and evidence in ways that meet FDA labeling requirements and Health Canada labeling rules. Missing this alignment risks costly delays, enforcement actions, and lost market opportunities. In this post, you\u2019ll learn how a clear claims substantiation approach can simplify compliance, speed approvals, and reduce regulatory risk across the US and Canadian markets. <a href=\"https:\/\/arora297consultancy.com\" target=\"_blank\">https:\/\/acenth.com\/blog\/medical-product-labeling-its-clinical-and-regulatory-significance\/<\/a><\/p>\n<h2 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Labeling Compliance Essentials<\/h2>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Understanding and aligning with labeling regulations is crucial for success in the US and Canadian markets. This section covers the essentials you need to know about FDA and Health Canada labeling requirements.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Navigating FDA Labeling Requirements<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">When it comes to FDA labeling, precision is key. The FDA outlines specific guidelines that ensure labels are informative and truthful. Missteps can lead to significant setbacks. Start by clearly defining your product category, as this determines the applicable regulations. Labels must include necessary product information like ingredients, usage instructions, and safety warnings. Remember, each detail must be supported by evidence. Regularly review the FDA&#8217;s guidelines to stay compliant. Mislabeling can result in product recalls or fines. Use resources like <a href=\"https:\/\/www.eurofinsus.com\/food-testing\/resources\/fda-label-claims-definitions-and-compliance-considerations\/\" target=\"_blank\">FDA Label Claims<\/a> for further guidance.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Understanding Health Canada Labeling<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Health Canada has its own set of labeling rules that emphasize clarity and accuracy. Labels must be bilingual and include product specifics such as ingredients and potential risks. Ensure claims on the label are substantiated with evidence. Health Canada frequently updates its guidelines, so staying informed is essential. Missteps here can delay market entry and affect credibility. Utilize resources like <a href=\"https:\/\/www.foodresearchlab.com\/insights\/regulation-updates\/china-labeling-claim-validation-global-standards\/\" target=\"_blank\">Health Canada Regulatory Requirements<\/a> to align your labels with current standards.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Key Elements in Medical Device Labeling<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Medical devices face unique labeling challenges. Labels must clearly convey product use, risks, and classification. The FDA and Health Canada both require detailed documentation to support claims. A clear understanding of Universal Device Identification (UDI) is crucial for tracking and compliance. Additionally, labels should reflect risk-based regulatory approaches to ensure safety. Regular audits and updates to your labeling strategy can prevent compliance issues.<\/p>\n<h2 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Claims Substantiation and Evidence<\/h2>\n<p><img decoding=\"async\" data-blockid=\"replaceWithId\" data-float=\"center\" data-href=\"\" src=\"https:\/\/blaze-media-uploads-for-dev.s3.us-west-1.amazonaws.com\/nano_banana_generated-3559ac4384ef2eaf34f1.png\" alt=\"\" title=\"\" data-media-file-id=\"SQQ0rBVg76lEQ8g2nfyeenMutzzL2LEJ\" style=\"max-width: 100%;height: auto;display: block;margin: 0 auto;\"><\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Building a robust claims substantiation framework is critical for regulatory compliance. Here&#8217;s how to align your claims with evidence effectively.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Building a Defensible Substantiation Matrix<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Creating a substantiation matrix ensures your claims are backed by solid evidence. Start by listing all claims and matching each one with supporting documents. This includes clinical studies, peer-reviewed articles, and expert opinions. The matrix not only helps in compliance but also aids in regulatory audits. It\u2019s essential to update this matrix regularly as new information or research becomes available. This proactive approach minimizes regulatory risks and accelerates approval processes.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Gathering Clinical Evidence Dossier<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">A comprehensive clinical evidence dossier is a must for claims substantiation. It should include detailed reports from clinical trials, observational studies, and expert consensus. Each piece of evidence should directly support your product&#8217;s claims. Organize the dossier for easy access during audits or submissions. Regularly update it with new findings to maintain its relevance. This dossier is your defensive line against claims challenges and ensures smoother regulatory interactions.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Conducting Systematic Literature Reviews<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Systematic literature reviews are crucial in gathering comprehensive evidence. This process involves identifying, evaluating, and synthesizing all relevant studies on your product. A thorough review will highlight the strengths of your claims and identify any gaps. It supports your substantiation matrix and enhances your clinical evidence dossier. Regularly updating these reviews ensures your claims remain defensible and compliant with evolving regulations.<\/p>\n<h2 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Compliance Strategies for Success<\/h2>\n<p><img decoding=\"async\" data-blockid=\"replaceWithId\" data-float=\"center\" data-href=\"\" src=\"https:\/\/blaze-media-uploads-for-dev.s3.us-west-1.amazonaws.com\/nano_banana_generated-6fe33c3e3f571510c3dd.jpg\" alt=\"\" title=\"\" data-media-file-id=\"6zcwQ4z6J8L9Y6WWbKJst4q5ub0UsRX6\" style=\"max-width: 100%;height: auto;display: block;margin: 0 auto;\"><\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Developing a strategic approach to compliance can significantly improve market entry success.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Crafting a Regulatory Strategy for US and Canada<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">A well-crafted regulatory strategy is essential for navigating the US and Canadian markets. This involves understanding the nuances of each regulatory body and aligning your product&#8217;s features and claims accordingly. Create a timeline for submission and approval processes to avoid unnecessary delays. Regularly consult with regulatory experts to refine your strategy and ensure it remains compliant with current guidelines.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Streamlining 510(k) Submission and DIN Application<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">The 510(k) submission process in the US and DIN application in Canada require meticulous preparation. Streamline these processes by ensuring all documentation is complete and up-to-date. Utilize templates and checklists to cover all regulatory requirements. Engage with regulatory consultants to ensure your submissions are robust and error-free. This proactive approach reduces the chances of rejection and accelerates market access.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Ensuring GMP and QMS Compliance<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Good Manufacturing Practices (GMP) and Quality Management Systems (QMS) are foundational to regulatory success. Regular audits and updates to these systems ensure continuous compliance. Maintain detailed records of all processes and changes. Invest in training for your team to stay updated on best practices. This commitment to quality not only meets regulatory expectations but also enhances product credibility and consumer trust.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">By following these guidelines and leveraging expert support, you can navigate the complexities of regulatory compliance with confidence. Reach out to Arora 297 Consultancy for tailored strategies and solutions that align with your business goals.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">\n","protected":false},"excerpt":{"rendered":"<p>Align labeling, claims, and evidence per FDA and Health Canada rules to avoid delays and enforcement. Use substantiation matrices, clinical evidence, and strategic regulatory planning for US and Canada compliance.<\/p>\n","protected":false},"author":1,"featured_media":999,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[79],"tags":[177,356,1454,329,285,1183,1448,1456,1449,368,209,154,1301,1450,1451,535,1452,1232,1457,1453,1455,563],"class_list":["post-1000","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-avinash-k-arora","tag-510k-submission","tag-claims-substantiation","tag-clinical-evidence-dossier","tag-cosmetic-claims-compliance","tag-din-application","tag-drug-facts-labeling","tag-fda-labeling-requirements","tag-gmp-and-qms-compliance","tag-health-canada-labeling","tag-iso-13485","tag-labeling-compliance","tag-mdel-registration","tag-mdl-licensing","tag-medical-device-labeling","tag-natural-health-product-evidence","tag-npn-application","tag-promotional-review","tag-regulatory-strategy-us-canada","tag-risk-based-regulatory-approach","tag-substantiation-matrix","tag-systematic-literature-review","tag-udi-requirements"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Align labeling, claims, and evidence per FDA and Health Canada rules to avoid delays and enforcement. Use substantiation matrices, clinical evidence, and strategic regulatory planning for US and Canada compliance.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Arora 297 Consultancy - Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada - Arora 297 Consultancy\" \/>\n\t\t<meta property=\"og:description\" content=\"Align labeling, claims, and evidence per FDA and Health Canada rules to avoid delays and enforcement. Use substantiation matrices, clinical evidence, and strategic regulatory planning for US and Canada compliance.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-06-23T13:00:35+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-06-23T13:00:35+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/consultingwithoutboundaries\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada - Arora 297 Consultancy\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Align labeling, claims, and evidence per FDA and Health Canada rules to avoid delays and enforcement. Use substantiation matrices, clinical evidence, and strategic regulatory planning for US and Canada compliance.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#blogposting\",\"name\":\"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada - Arora 297 Consultancy\",\"headline\":\"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada\",\"author\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/featured-image-1782219629.jpeg\",\"width\":1200,\"height\":896},\"datePublished\":\"2026-06-23T13:00:35+00:00\",\"dateModified\":\"2026-06-23T13:00:35+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#webpage\"},\"articleSection\":\"Regulatory Insights, 510(k) submission, claims substantiation, clinical evidence dossier, cosmetic claims compliance, DIN application, Drug Facts labeling, FDA labeling requirements, GMP and QMS compliance, Health Canada labeling, ISO 13485, labeling compliance, MDEL registration, MDL licensing, medical device labeling, natural health product evidence, NPN application, promotional review, regulatory strategy US Canada, risk-based regulatory approach, substantiation matrix, systematic literature review, UDI requirements\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/#listItem\",\"name\":\"Arora 297 Consultancy\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/#listItem\",\"position\":2,\"name\":\"Arora 297 Consultancy\",\"item\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/avinash-k-arora\\\/#listItem\",\"name\":\"Regulatory Insights\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/avinash-k-arora\\\/#listItem\",\"position\":3,\"name\":\"Regulatory Insights\",\"item\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/avinash-k-arora\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#listItem\",\"name\":\"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/#listItem\",\"name\":\"Arora 297 Consultancy\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#listItem\",\"position\":4,\"name\":\"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/avinash-k-arora\\\/#listItem\",\"name\":\"Regulatory Insights\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#organization\",\"name\":\"Arora 297 Consultancy\",\"description\":\"Senior-led Health Canada and FDA regulatory consulting for medical devices, natural health products, cosmetics, food, and biocides \\u2014 backed by 20+ years of experience, 1,000+ successful submissions, and a 98% audit success rate. Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance Health Canada &amp; FDA Regulatory Consulting\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/\",\"email\":\"info@arora297consultancy.com\",\"telephone\":\"+15194985957\",\"foundingDate\":\"2020-01-23\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":2,\"maxValue\":4},\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.arora297consultancy.com\\\/assets\\\/media\\\/general\\\/logo.png\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/consultingwithoutboundaries\\\/\",\"https:\\\/\\\/www.instagram.com\\\/arora297consultancy\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/arora-297-consultancy\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9c4b4c0b5727c4eaa4bbf02b476c099d4d7bb4a1fdceeafb6890a386e37d0bc6?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#webpage\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/\",\"name\":\"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada - Arora 297 Consultancy\",\"description\":\"Align labeling, claims, and evidence per FDA and Health Canada rules to avoid delays and enforcement. Use substantiation matrices, clinical evidence, and strategic regulatory planning for US and Canada compliance.\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/featured-image-1782219629.jpeg\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#mainImage\",\"width\":1200,\"height\":896},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\\\/#mainImage\"},\"datePublished\":\"2026-06-23T13:00:35+00:00\",\"dateModified\":\"2026-06-23T13:00:35+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/\",\"name\":\"Arora 297 Consultancy\",\"alternateName\":\"A297C\",\"description\":\"Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada - Arora 297 Consultancy","description":"Align labeling, claims, and evidence per FDA and Health Canada rules to avoid delays and enforcement. Use substantiation matrices, clinical evidence, and strategic regulatory planning for US and Canada compliance.","canonical_url":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#blogposting","name":"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada - Arora 297 Consultancy","headline":"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada","author":{"@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/arora297consultancy.com\/blog\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/arora297consultancy.com\/blog\/wp-content\/uploads\/2026\/06\/featured-image-1782219629.jpeg","width":1200,"height":896},"datePublished":"2026-06-23T13:00:35+00:00","dateModified":"2026-06-23T13:00:35+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#webpage"},"isPartOf":{"@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#webpage"},"articleSection":"Regulatory Insights, 510(k) submission, claims substantiation, clinical evidence dossier, cosmetic claims compliance, DIN application, Drug Facts labeling, FDA labeling requirements, GMP and QMS compliance, Health Canada labeling, ISO 13485, labeling compliance, MDEL registration, MDL licensing, medical device labeling, natural health product evidence, NPN application, promotional review, regulatory strategy US Canada, risk-based regulatory approach, substantiation matrix, systematic literature review, UDI requirements"},{"@type":"BreadcrumbList","@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog#listItem","position":1,"name":"Home","item":"https:\/\/arora297consultancy.com\/blog","nextItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/#listItem","name":"Arora 297 Consultancy"}},{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/#listItem","position":2,"name":"Arora 297 Consultancy","item":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/","nextItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/#listItem","name":"Regulatory Insights"},"previousItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/#listItem","position":3,"name":"Regulatory Insights","item":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/","nextItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#listItem","name":"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada"},"previousItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/#listItem","name":"Arora 297 Consultancy"}},{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#listItem","position":4,"name":"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada","previousItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/#listItem","name":"Regulatory Insights"}}]},{"@type":"Organization","@id":"https:\/\/arora297consultancy.com\/blog\/#organization","name":"Arora 297 Consultancy","description":"Senior-led Health Canada and FDA regulatory consulting for medical devices, natural health products, cosmetics, food, and biocides \u2014 backed by 20+ years of experience, 1,000+ successful submissions, and a 98% audit success rate. Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance Health Canada &amp; FDA Regulatory Consulting","url":"https:\/\/arora297consultancy.com\/blog\/","email":"info@arora297consultancy.com","telephone":"+15194985957","foundingDate":"2020-01-23","numberOfEmployees":{"@type":"QuantitativeValue","minValue":2,"maxValue":4},"logo":{"@type":"ImageObject","url":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png","@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#organizationLogo"},"image":{"@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/consultingwithoutboundaries\/","https:\/\/www.instagram.com\/arora297consultancy\/","https:\/\/www.linkedin.com\/company\/arora-297-consultancy\/"]},{"@type":"Person","@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author","url":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/9c4b4c0b5727c4eaa4bbf02b476c099d4d7bb4a1fdceeafb6890a386e37d0bc6?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#webpage","url":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/","name":"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada - Arora 297 Consultancy","description":"Align labeling, claims, and evidence per FDA and Health Canada rules to avoid delays and enforcement. Use substantiation matrices, clinical evidence, and strategic regulatory planning for US and Canada compliance.","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/arora297consultancy.com\/blog\/#website"},"breadcrumb":{"@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#breadcrumblist"},"author":{"@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author"},"creator":{"@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/arora297consultancy.com\/blog\/wp-content\/uploads\/2026\/06\/featured-image-1782219629.jpeg","@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#mainImage","width":1200,"height":896},"primaryImageOfPage":{"@id":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/#mainImage"},"datePublished":"2026-06-23T13:00:35+00:00","dateModified":"2026-06-23T13:00:35+00:00"},{"@type":"WebSite","@id":"https:\/\/arora297consultancy.com\/blog\/#website","url":"https:\/\/arora297consultancy.com\/blog\/","name":"Arora 297 Consultancy","alternateName":"A297C","description":"Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance","inLanguage":"en-US","publisher":{"@id":"https:\/\/arora297consultancy.com\/blog\/#organization"}}]},"og:locale":"en_US","og:site_name":"Arora 297 Consultancy - Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance","og:type":"article","og:title":"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada - Arora 297 Consultancy","og:description":"Align labeling, claims, and evidence per FDA and Health Canada rules to avoid delays and enforcement. Use substantiation matrices, clinical evidence, and strategic regulatory planning for US and Canada compliance.","og:url":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/","og:image":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png","og:image:secure_url":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png","article:published_time":"2026-06-23T13:00:35+00:00","article:modified_time":"2026-06-23T13:00:35+00:00","article:publisher":"https:\/\/www.facebook.com\/consultingwithoutboundaries\/","twitter:card":"summary_large_image","twitter:title":"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada - Arora 297 Consultancy","twitter:description":"Align labeling, claims, and evidence per FDA and Health Canada rules to avoid delays and enforcement. Use substantiation matrices, clinical evidence, and strategic regulatory planning for US and Canada compliance.","twitter:image":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png"},"aioseo_meta_data":{"post_id":"1000","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-06-23 14:12:27","updated":"2026-06-23 14:12:27","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/arora297consultancy.com\/blog\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/\" title=\"Arora 297 Consultancy\">Arora 297 Consultancy<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/\" title=\"Regulatory Insights\">Regulatory Insights<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tHow to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/arora297consultancy.com\/blog"},{"label":"Arora 297 Consultancy","link":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/"},{"label":"Regulatory Insights","link":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/"},{"label":"How to Align Labeling, Claims, and Evidence for Regulated Product Compliance in the US and Canada","link":"https:\/\/arora297consultancy.com\/blog\/how-to-align-labeling-claims-and-evidence-for-regulated-product-compliance-in-the-us-and-canada\/"}],"_links":{"self":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/posts\/1000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/comments?post=1000"}],"version-history":[{"count":0,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/posts\/1000\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/media\/999"}],"wp:attachment":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/media?parent=1000"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/categories?post=1000"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/tags?post=1000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}